FDA Import Refusal 799-4545710-8/11/2 — ELI LILLY AND COMPANY
The FDA refused shipment 799-4545710-8/11/2 from ELI LILLY AND COMPANY (United States) on Sep 15, 2021. The refused product falls under Drugs and Biologics — LISPRO INSULIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 15, 2021
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61PCK54 LISPRO INSULIN (ANTI-DIABETIC)
- Charges
- 75